Healthpeak Properties (NYSE:DOC) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says

Healthpeak Properties (NYSE:DOC) had its price target lifted by stock analysts at Royal Bank Of Canada from $20.00 to $21.00 in a report issued on Thursday,Benzinga reports. The brokerage presently has an “outperform” rating on the real estate investment trust’s stock. Royal Bank Of Canada’s price target indicates a potential upside of 6.38% from the company’s previous close.

Other analysts have also issued reports about the stock. Argus lowered shares of Healthpeak Properties from a “buy” rating to a “hold” rating in a report on Thursday, February 5th. Evercore downgraded shares of Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 target price for the company. in a report on Monday. Weiss Ratings upgraded shares of Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, May 8th. UBS Group lifted their target price on shares of Healthpeak Properties from $17.00 to $19.00 and gave the company a “neutral” rating in a report on Wednesday. Finally, Wall Street Zen upgraded shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a report on Sunday. Five research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $18.92.

Healthpeak Properties Trading Up 1.0%

Shares of Healthpeak Properties stock traded up $0.19 during trading hours on Thursday, hitting $19.74. The company’s stock had a trading volume of 1,988,947 shares, compared to its average volume of 9,147,439. Healthpeak Properties has a twelve month low of $15.70 and a twelve month high of $19.91. The firm has a fifty day moving average of $17.19 and a 200-day moving average of $17.19. The stock has a market cap of $13.61 billion, a price-to-earnings ratio of 61.74, a P/E/G ratio of 2.73 and a beta of 1.00. The company has a debt-to-equity ratio of 1.15, a quick ratio of 2.96 and a current ratio of 2.96.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.02. The firm had revenue of $752.95 million for the quarter, compared to analyst estimates of $694.59 million. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. Healthpeak Properties’s revenue was up 7.1% on a year-over-year basis. During the same period in the previous year, the firm earned $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Research analysts forecast that Healthpeak Properties will post 1.74 EPS for the current year.

Insider Transactions at Healthpeak Properties

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total transaction of $213,736.05. Following the sale, the insider directly owned 7,636 shares in the company, valued at $148,520.20. This represents a 59.00% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.23% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Healthpeak Properties

Hedge funds have recently added to or reduced their stakes in the business. CoreCap Advisors LLC increased its holdings in Healthpeak Properties by 22.4% during the 3rd quarter. CoreCap Advisors LLC now owns 3,352 shares of the real estate investment trust’s stock worth $64,000 after purchasing an additional 613 shares during the period. Fiduciary Trust Co increased its holdings in Healthpeak Properties by 4.9% during the 3rd quarter. Fiduciary Trust Co now owns 13,807 shares of the real estate investment trust’s stock worth $264,000 after purchasing an additional 644 shares during the period. Patton Fund Management Inc. increased its holdings in Healthpeak Properties by 5.2% during the 4th quarter. Patton Fund Management Inc. now owns 13,002 shares of the real estate investment trust’s stock worth $209,000 after purchasing an additional 648 shares during the period. Arjuna Capital increased its holdings in Healthpeak Properties by 4.8% during the 3rd quarter. Arjuna Capital now owns 14,768 shares of the real estate investment trust’s stock worth $283,000 after purchasing an additional 679 shares during the period. Finally, Quadrant Capital Group LLC increased its holdings in Healthpeak Properties by 1.9% during the 3rd quarter. Quadrant Capital Group LLC now owns 37,650 shares of the real estate investment trust’s stock worth $721,000 after purchasing an additional 718 shares during the period. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.